Presentation is loading. Please wait.

Presentation is loading. Please wait.

Chronic effect of 28-day oral administration of vehicle (n = 6–10/group) or aprocitentan 1, 10, and 100 mg/kg per day (n = 6–9/group) on mean arterial.

Published by债原 冉 Modified over 5 years ago

Similar presentations

Presentation on theme: "Chronic effect of 28-day oral administration of vehicle (n = 6–10/group) or aprocitentan 1, 10, and 100 mg/kg per day (n = 6–9/group) on mean arterial."— Presentation transcript:

1 Chronic effect of 28-day oral administration of vehicle (n = 6–10/group) or aprocitentan 1, 10, and 100 mg/kg per day (n = 6–9/group) on mean arterial pressure (A), heart rate (B), renal vascular resistance (C), left ventricle plus septum/heart weight ratio (D), and N-terminal pro b-type natriuretic peptide (NT-proBNP) plasma concentrations (E) in DOCA-salt rats. Chronic effect of 28-day oral administration of vehicle (n = 6–10/group) or aprocitentan 1, 10, and 100 mg/kg per day (n = 6–9/group) on mean arterial pressure (A), heart rate (B), renal vascular resistance (C), left ventricle plus septum/heart weight ratio (D), and N-terminal pro b-type natriuretic peptide (NT-proBNP) plasma concentrations (E) in DOCA-salt rats. Wistar rats (n = 6/group) served as control. Data are presented as mean ± S.E.M.; “w” denotes week after DOCA-salt treatment initiation; *P < 0.05 compared with vehicle-treated DOCA-salt rats. Frederic Trensz et al. J Pharmacol Exp Ther 2019;368: Copyright © 2019 The Author(s).

Download ppt "Chronic effect of 28-day oral administration of vehicle (n = 6–10/group) or aprocitentan 1, 10, and 100 mg/kg per day (n = 6–9/group) on mean arterial."

Similar presentations

Comparison of the diagnostic accuracy of BNP & NTPro-BNP in Acute and Chronic Heart Failure by Jamie Al-Nasir.

Comparison of the diagnostic accuracy of BNP & NTPro-BNP in Acute and Chronic Heart Failure by Jamie Al-Nasir.
Admission B-Type Natriuretic Peptide Levels and In-Hospital Mortality in Acute Decompensated Heart Failure Fonarow GC et al. J Am Coll Cardiol 2007; 49(19):1943-1950.

Admission B-Type Natriuretic Peptide Levels and In-Hospital Mortality in Acute Decompensated Heart Failure Fonarow GC et al. J Am Coll Cardiol 2007; 49(19):
The Vicious Cycle of Chronic Congestive Heart Failure.

The Vicious Cycle of Chronic Congestive Heart Failure.
Date of download: 7/7/2016 Copyright © The American College of Cardiology. All rights reserved. From: Acute Phosphodiesterase 5 Inhibition Mimics Hemodynamic.

Date of download: 7/7/2016 Copyright © The American College of Cardiology. All rights reserved. From: Acute Phosphodiesterase 5 Inhibition Mimics Hemodynamic.
Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: Angiotensin II type 1 receptor antagonist decreases.

Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: Angiotensin II type 1 receptor antagonist decreases.
Kidney Blood Press Res 2013;37: DOI: /

Kidney Blood Press Res 2013;37: DOI: /
Antioxidant Treatment Prevents Renal Damage and Dysfunction and Reduces Arterial Pressure in Salt-Sensitive Hypertension by Niu Tian, Kristina D. Thrasher,

Antioxidant Treatment Prevents Renal Damage and Dysfunction and Reduces Arterial Pressure in Salt-Sensitive Hypertension by Niu Tian, Kristina D. Thrasher,
Stephen W. Waldo et al. JACC 2008;51:

Stephen W. Waldo et al. JACC 2008;51:
Median NT-proBNP levels (pg/mL) by GFR and 60-day survival

Median NT-proBNP levels (pg/mL) by GFR and 60-day survival
by Victor R. Gordeuk, Oswaldo L. Castro, and Roberto F. Machado

by Victor R. Gordeuk, Oswaldo L. Castro, and Roberto F. Machado
Clyde W. Yancy et al. JACC 2017;70:

Clyde W. Yancy et al. JACC 2017;70:
Figure 1. Plasma urea concentrations in apolipoprotein E–deficient (apo-E −/−) mice with chronic renal failure (CRF). Figure 1. Plasma urea concentrations.

Figure 1. Plasma urea concentrations in apolipoprotein E–deficient (apo-E −/−) mice with chronic renal failure (CRF). Figure 1. Plasma urea concentrations.
Metabolic effects of K107R and rosiglitazone treatment.

Metabolic effects of K107R and rosiglitazone treatment.
G. Michael Felker et al. JCHF 2014;2:

G. Michael Felker et al. JCHF 2014;2:
Editorial Heart Failure Clinics

Editorial Heart Failure Clinics
Incremental predictive value of CR after repetitive squatting exercise and FC from cardiopulmonary testing exercise results over clinical (red) and echocardiographic.

Incremental predictive value of CR after repetitive squatting exercise and FC from cardiopulmonary testing exercise results over clinical (red) and echocardiographic.
Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery  Olaf Schouten, MD, Sanne.

Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery  Olaf Schouten, MD, Sanne.
Inhibition of FGFR signaling and tumor growth in SNU-16 xenograft model by administration of E7090. Inhibition of FGFR signaling and tumor growth in SNU-16.

Inhibition of FGFR signaling and tumor growth in SNU-16 xenograft model by administration of E7090. Inhibition of FGFR signaling and tumor growth in SNU-16.
Hepatorenal syndrome in cirrhosis: Pathogenesis and treatment

Hepatorenal syndrome in cirrhosis: Pathogenesis and treatment
Fig. 2. Effects of SFN in mouse hepatocytes and in rat models of diet-induced glucose intolerance. Effects of SFN in mouse hepatocytes and in rat models.

Fig. 2. Effects of SFN in mouse hepatocytes and in rat models of diet-induced glucose intolerance. Effects of SFN in mouse hepatocytes and in rat models.

Similar presentations

Ads by Google